Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia, 8 Weeks, Phase 3, Randomized, Double-blind, Active-control, Multinational, Multi-center, Parallel Study
The purpose of this study is to demonstrate the superiority of atorvastatin/perindopril fixed dose combination (FDC) S05167 as compared to atorvastatin reference drug alone or perindopril drug alone on systolic blood pressure decrease and LDL cholesterol decrease respectively in patients presenting with hypertension and dyslipidemia after 8 weeks of treatment.
100 项与 阿托伐他汀/培哚普利 相关的临床结果
100 项与 阿托伐他汀/培哚普利 相关的转化医学
100 项与 阿托伐他汀/培哚普利 相关的专利(医药)
100 项与 阿托伐他汀/培哚普利 相关的药物交易